| Jane Farley Anderson, RN | |
|
1950 Drew St, Annapolis, MD 21401-3913 | |
| (410) 222-7247 | |
| Not Available |
| Full Name | Jane Farley Anderson |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1950 Drew St, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396980264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R061062 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jane Farley Anderson, RN 1950 Drew Street, Parole Health Center, Annapolis, MD 21401 Ph: (410) 222-7247 | Jane Farley Anderson, RN 1950 Drew St, Annapolis, MD 21401-3913 Ph: (410) 222-7247 |
News Archive
With so many new drugs on the market to treat arthritis and related disorders, how do doctors know which ones to use?
Proton Therapy USA and CareCapital plc announced today the formation of Proton Therapy Global Management (PTGM). The Company will design, develop and manage a global network of proton therapy centers, providing access to this specialized and highly effective treatment to the world's growing population of cancer patients. Proton therapy is a precise form of radiation treatment that has been very successful in treating a wide range of localized tumors, while leaving healthy tissue mostly intact.
For discoveries about how the brain calculates and remembers where it is—which could be part of the foundation of memory—Columbia University will award the 2013 Louisa Gross Horwitz Prize to Edvard I. Moser, PhD, and May-Britt Moser, PhD, of the Norwegian University of Science and Technology in Norway, and John Michael O'Keefe, PhD, of University College London in the UK.
A functional biomarker that can predict whether BRAF-mutant melanomas respond to drugs targeting BRAF could help guide the treatment of patients with these cancers, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.
Researchers from the Boston area, Mexico, and Norway have completed a comprehensive genomic analysis of cervical cancer in two patient populations. The study identified recurrent genetic mutations not previously found in cervical cancer, including at least one for which targeted treatments have been approved for other forms of cancer.
› Verified 7 days ago
Mrs. Chase Ryan Best, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1302 Colony Dr, Annapolis, MD 21403 Phone: 443-822-4493 | |
Linda Aveni Murray, CRNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Forbes St, Suite 200, Annapolis, MD 21401 Phone: 410-263-6363 Fax: 410-263-4086 | |
Sharlene Howard, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Harry S Truman Pkwy, Suite 234, Ms-3103, Annapolis, MD 21401 Phone: 410-222-4082 | |
Ms. Hellen Joan Butler, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Harry S Truman Pkwy Ste 200, Annapolis, MD 21401 Phone: 410-222-7256 | |
Stephanie Bladen, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Pkwy, Annapolis, MD 21401 Phone: 410-571-9700 | |
Ms. Cyrilla Bollinger Rohrer, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3 Harry S Truman Pkwy, Hd 8, Annapolis, MD 21401 Phone: 410-222-4465 | |
Dr. Sarah K Keenan, DNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1125 West St Ste 316, Annapolis, MD 21401 Phone: 240-771-5793 |